A collaborative sequential meta-analysis of individual patient data from randomized trials of endovascular therapy and tPA vs. tPA alone for acute ischemic stroke: ThRombEctomy And tPA (TREAT) analysis: Statistical analysis plan for a sequential meta-analysis performed within the VISTA-Endovascular collaboration

International Journal of Stroke

Volumn 10, Issue A100, 2015, Pages 136-144

  Macisaac, Rachael L ^a   Khatri, Pooja ^b   Bendszus, Martin ^c   Bracard, Serge ^d   Broderick, Joseph ^b   Campbell, Bruce ^e   Ciccone, Alfonso ^f   Dávalos, Antoni ^g   Davis, Stephen M ^e   Demchuk, Andrew ^h   Diener, Hans Christoph ⁱ   Dippel, Diederik ^j   Donnan, Geoffrey A ^k   Fiehler, Jens ^l   Fiorella, David ^m   Goyal, Mayank ⁿ   Hacke, Werner ^o   Hill, Michael D ^h   Jahan, Reza ^p   Jauch, Edward ^q   Jovin, Tudor ^r   Kidwell, Chelsea S ^s   Liebeskind, David ^t   Majoie, Charles B ^u   Martins, Sheila Cristina Ouriques ^v   Mitchell, Peter ^k   Mocco, J ^w   Muir, Keith W ^x,y   Nogueira, Raul ^z   Saver, Jeffrey L ^t   Schonewille, Wouter J ^aa   Siddiqui, Adnan H ^ab   Thomalla, Götz ^l   Tomsick, Thomas A ^b   Turk, Aquilla S ^ac   White, Philip ^ad   Zaidat, Osama ^ae   Lees, Kennedy R ^a   more..

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF CINCINNATI   (United States)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^d UNIVERSITY HOSPITAL OF NANCY   (France)

^e ROYAL MELBOURNE HOSPITAL   (Australia)

^f CARLO POMA HOSPITAL   (Italy)

^g HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^h UNIVERSITY OF CALGARY   (Canada)

ⁱ UNIVERSITY HOSPITAL ESSEN   (Germany)

^j ERASMUS MEDICAL CENTER   (Netherlands)

^k UNIVERSITY OF MELBOURNE   (Australia)

^l UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^m STONY BROOK UNIVERSITY   (United States)

ⁿ UNIVERSITY OF CALGARY   (Canada)

^o UNIVERSITY OF HEIDELBERG   (Germany)

^p UNIVERSITY OF CALIFORNIA   (United States)

^q MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^r UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^s UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^t UNIVERSITY OF CALIFORNIA   (United States)

^u ACADEMIC MEDICAL CENTER   (Netherlands)

^v HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^w MOUNT SINAI HOSPITAL   (United States)

^x UNIVERSITY OF GLASGOW   (United Kingdom)

^y SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^z MASSACHUSETTS GENERAL HOSPITAL   (United States)

^aa ST ANTONIUS HOSPITAL   (Netherlands)

^ab UNIVERSITY AT BUFFALO   (United States)

^ac MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^ad NEWCASTLE UNIVERSITY   (United Kingdom)

^ae MEDICAL COLLEGE OF WISCONSIN   (United States)

more..

Author keywords

Acute; Endovascular; Ischemic stroke; Meta analysis; Protocols; Treatment

Indexed keywords

ALTEPLASE; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BLOOD CLOT LYSIS; BRAIN ISCHEMIA; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; DATA ANALYSIS; DRUG EFFICACY; HUMAN; INTENTION TO TREAT ANALYSIS; META ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RANKIN SCALE; THROMBECTOMY; TREATMENT OUTCOME; ANALYSIS OF VARIANCE; COOPERATION; ENDOVASCULAR SURGERY; FEMALE; MALE; META ANALYSIS (TOPIC); PROCEDURES; STROKE;

ANALYSIS OF VARIANCE; COOPERATIVE BEHAVIOR; ENDOVASCULAR PROCEDURES; FEMALE; HUMANS; MALE; META-ANALYSIS AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STROKE; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 84946406373     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/ijs.12622     Document Type: Article

References (32)

1. Lees KR, Bluhmki E, von Kummer R etal. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010; 375:1695-1703.
2. Emberson J, Lees KR, Lyden P etal. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 2014; 384:1929-1935.
3. Saver JL, Jahan R, Levy EI etal. Solitaire flow restoration device versus the merci retriever in patients with acute ischaemic stroke (swift): a randomised, parallel-group, non-inferiority trial. Lancet 2012; 380:1241-1249.
4. Nogueira RG, Lutsep HL, Gupta R etal. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet 2012; 380:1231-1240.
5. Kidwell CS, Jahan R, Alger JR etal. Design and rationale of the mechanical retrieval and recanalization of stroke clots using embolectomy (MR RESCUE) trial. Int J Stroke 2012; 13:1747-4949.
6. Broderick JP, Palesch YY, Demchuk AM etal. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. NEJM 2013; 368:893-903.
7. Ciccone A, Valvassori L, Nichelatti M etal. Endovascular treatment for acute ischemic stroke. NEJM 2013; 368:904-913.
8. Berkhemer OA, Fransen PSS, Beumer D etal. A randomized trial of intraarterial treatment for acute ischemic stroke. NEJM 2015; 372:11-20.
9. Goyal M, Demchuk AM, Menon BK etal. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 2015; 372:1019-1030.
10. Campbell BC, Mitchell PJ, Kleinig TJ etal. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 2015; 372:1009-1018.
11. Saver JL, Goyal M, Bonafe A etal. Solitaire with the intention for thrombectomy as primary endovascular treatment for acute ischemic stroke (SWIFT PRIME) trial: protocol for a randomized, controlled, multicenter study comparing the solitaire revascularization device with iv tPA with iv tPA alone in acute ischemic stroke. Int J Stroke 2015; 10:439-448.
12. Molina CA, Chamorro A, Rovira À etal. Revascat: a randomized trial of revascularization with solitaire fr® device vs. Best medical therapy in the treatment of acute stroke due to anterior circulation large vessel occlusion presenting within eight-hours of symptom onset. Int J Stroke 2015; 10:619-626.
13. Fargen KM, Neal D, Fiorella DJ, Turk AS, Froehler M, Mocco J. A meta-analysis of prospective randomized controlled trials evaluating endovascular therapies for acute ischemic stroke. J Neurointerv Surg 2015; 7:84-89.
14. Furlan A, Higashida R, Wechsler L etal. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. JAMA 1999; 282:2003-2011.
15. Ogawa A, Mori E, Minematsu K etal. Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the middle cerebral artery embolism local fibrinolytic intervention trial (MELT) Japan. Stroke 2007; 38:2633-2639.
16. Kidwell CS, Jahan R, Gornbein J etal. A trial of imaging selection and endovascular treatment for ischemic stroke. NEJM 2013; 368:914-923.
17. Khatri P, Hacke W, Fiehler J etal. State of acute endovascular therapy: report from the 12th thrombolysis, thrombectomy, and acute stroke therapy conference. Stroke 2015; 46:1727-1734.
18. Higgins JPT, Whitehead A, Simmonds M. Sequential methods for random-effects meta-analysis. Stat Med 2011; 30:903-921.
19. van der Tweel I, Bollen C. Sequential meta-analysis: an efficient decision-making tool. Clin Trials 2010; 7:136-146.
20. Berkey CS, Mosteller F, Lau J, Antman EM. Uncertainty of the time of first significance in random effects cumulative meta-analysis. Control Clin Trials 1996; 17:357-371.
21. Whitehead A. Meta-analysis of Controlled Clinical Trials. Chichester, West Sussex, John Wiley and Sons, 2002.
22. Bolland K, Whitehead J, Cobo E, Secades JJ. Evaluation of a sequential global test of improved recovery following stroke as applied to the ictus trial of citicoline. Pharm Stat 2009; 8:136-149.
23. Whitehead J. The Design and Analysis of Sequential Clinical Trials. Chichester, West Sussex, John Wiley and Sons, 1997.
24. Whitehead A. A prospectively planned cumulative meta-analysis applied to a series of concurrent clinical trials. Stat Med 1997; 16:2901-2913.
25. Whitehead J. Group sequential trials revisited: simple implementation using sas. Stat Methods Med Res 2011; 20:635-656.
26. Saver JL. Novel end point analytic techniques and interpreting shifts across the entire range of outcome scales in acute stroke trials. Stroke 2007; 38:3055-3062.
27. Carpenter JR, Kenward MG (eds). Sensitivity analysis: Mi unleashed; in Multiple Imputation and Its Application. Chichester, West Sussex, John Wiley & Sons, Ltd, 2013:229-268.
28. Whitehead J, Branson M, Todd S. A combined score test for binary and ordinal endpoints from clinical trials. Stat Med 2010; 29:521-532.
29. Wahlgren N, Ahmed N, Davalos A etal. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007; 369:275-282.
30. Saver JL. Optimal end points for acute stroke therapy trials. Stroke 2011; 42:2356-2362.
31. McHugh GS, Butcher I, Steyerberg EW etal. A simulation study evaluating approaches to the analysis of ordinal outcome data in randomized controlled trials in traumatic brain injury: results from the impact project. Clin Trials 2010; 7:44-57.
32. Rahlfs VW, Zimmermann H, Lees KR. Effect size measures and their relationships in stroke studies. Stroke 2014; 45:627-633.